Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(13 sites)

United States

UF Health Cancer Institute - Gainesville, Gainesville, Florida

Memorial Hospital East, Shiloh, Illinois

University of Kansas Clinical Research Center, Fairway, Kansas

University of Kansas Cancer Center, Kansas City, Kansas

University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas

University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas

Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri

Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri

Washington University School of Medicine, St Louis, Missouri

Siteman Cancer Center-South County, St Louis, Missouri

Siteman Cancer Center at Christian Hospital, St Louis, Missouri

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee